3-(2,2,2-trimethylhydrazine)propionate has been researched along with Asthenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belousova, YD; Reznik, EY; Tynterova, AM | 1 |
| Drokina, OV; Druk, IV; Dubileĭ, GS; Nechaeva, GI | 1 |
2 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Asthenia
| Article | Year |
|---|---|
[Clinical characteristics and metabolic therapy of fatigue in the acute and early recovery periods of ischemic stroke].
Topics: Aged; Asthenia; Fatigue; Humans; Ischemic Stroke; Middle Aged; Stroke; Syndrome | 2023 |
[Clinical experience of application mildronate at recovery treatment of patients with displazia connecting fabric].
Topics: Adult; Asthenia; Cardiovascular Agents; Connective Tissue Diseases; Drug Administration Routes; Drug Monitoring; Exercise Tolerance; Female; Heart Diseases; Heart Function Tests; Humans; Male; Methylhydrazines; Myocardial Contraction; Treatment Outcome | 2014 |